Bayer, BASF, Corteva urge federal court to review dicamba weedkiller ban, calling it ‘unconstitutional’

Spraying young cotton plants in a field

Bayer, BASF and Corteva Agriscience continue the fight to preserve postemergent dicamba use. The companies are contesting the results of a June 3 decision by three judges on the U.S. Circuit Court of Appeals for the Ninth Circuit, which vacated the registrations of their dicamba herbicides, XtendiMax, Engenia and FeXapan.

In the original decision, the three judges assigned to the case concluded that EPA had broken its own governing law when it re-registered the three herbicides in 2018 …. Now Bayer, BASF and Corteva are asking that a broader group of Ninth Circuit judges re-hear the case.

The companies argue that the judges’ decision to vacate the registrations effective immediately was a departure from past precedent among other Circuit Courts, as well as the Supreme Court, and violated principles of administrative and constitutional law.

Related article:  'Small victory' for Bayer: Judge says firm can move upcoming glyphosate trials to farm states

BASF and Corteva also reiterated an argument that the judges’ decision did not give them an opportunity to defend their herbicides, since the original lawsuit in 2017 only mentioned Bayer’s XtendiMax. Only when the case was re-filed in 2019 was it expanded to address EPA’s entire 2018 dicamba registration decision, which included Engenia and FeXapan.


BASF and Corteva argue that this new scope was not clear enough in the course of the lawsuit, and the companies weren’t aware their herbicides’ registrations were at stake before the June 3 ruling.

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend